Walden International Investment expands leadership team

The venture capital firm focuses its investments on biotechnology, software and internet with new additions to team.

Charles Hsu is the new general partner for Walden International Investment Group (WIIG), responsible for investments in the life sciences sector. Hsu began his venture capital career in 1990 with Advent International, where he was a partner. Eventually, Hsu moved to Walden VC where he was a partner immediately prior to this new appointment. At Walden VC, Hsu managed global investments in healthcare and the life sciences.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Share our publication on social media
Share our publication on social media